and found that MDA levels were higher in patients with glomerulonephritis (0.16±0.06 mM ) than in Background. Reactive oxygen species and particularly free radical induced lipid peroxidative tissue damage those with CRF from non-glomerular causes (0.12±0.04 mM, P=0.002). have been implicated in the pathogenesis of various renal diseases. Lipid peroxidation is assessed indirectly Conclusions. We have introduced a reliable and sensitive HPLC technique to enhance the specificity of by the measurement of secondary products, such as malondialdehyde (MDA), using the widely employed MDA-( TBA) 2 measurement, with a significant improvement in HPLC column life. Using this method, thiobarbituric acid reactive substances ( TBARS) method. However, this method lacks sensitivity and picomole quantities of MDA can be detected in plasma.
Results. The assay was linear over the ranges Introduction 0.25-1.0 mM MDA and the detection limit was 0.06 mM MDA. Within-run precision was <4.5% and Reactive oxygen species ( ROS) are mediators of between-run precision was <10.0%. MDA plasma vascular and tissue damage in various diseases, includconcentrations (mean±SD) were higher in ESRF ing diabetes, rheumatoid arthritis, and ischaemicdiabetic patients (0.32±0.14 mM, n=20), non-diabetic reperfusion injury [1] . They have been implicated in ESRF patients (0.32±0.09 mM, n=20), and CRF the pathogenesis of renal disease in various animal patients (0.14±0.06 mM, n=40) compared to healthy models of renal failure, including glomerulonephritis controls (0.11±0.03 mM, n=40), (P<0.001, P<0.001 [2] . There is also evidence to suggest increased free and P=0.008). Levels were similar in healthy controls radical activity during haemodialysis [3] and after renal with normal renal function and transplanted patients transplantation [4] . (0.12±0.03 mM MDA, n=40), (P=NS ) . No correla-
The identification and quantification of ROS by tion was observed between MDA and creatinine levels direct methods using electron spin resonance ( ESR) (r2=0.05, n=80), which suggests that MDA does not spectroscopy has been carried out in many cellular correlate with the degree of renal impairment. We systems. However, it is not a routine method of matched CRF patients with glomerular and nonanalysis, because of the expensive nature of the glomerular causes of renal failure for creatinine levels equipment and a lack of data regarding ESR spectra of in vivo biological systems. Alternatively, oxygen- column life and gives similar sensitivity to methods using post-column visible detection, without the need for complex sample preparation or organic Analytical procedure extractions.
To date, there are few data on HPLC analysis of The TBA assay was adapted from Chirico [11] . A MDA in biological fluids applied to samples from deproteinization step was developed and optimized in terms of protein recovery and sensitivity of calibration, using the patients with renal diseases. We report the validation following acids: phosphoric, trichloroacetic, or perchloric, and comparison of plasma samples obtained from and different extraction procedures and sample volumes. The healthy controls and various renal patients, including TBA incubation was carried out using various sample supertransplants, end-stage renal failure ( ESRF ) and natant and TBA reagent volumes. The optimized assay was chronic renal failure (CRF ) patients, with particular as follows: 250 ml plasma or standard was treated with 25 ml emphasis on patients suffering from glomerulonephritis 0.2% BHT (in absolute ethanol ), followed by addition of where ROS have been implicated as mediators of 1 ml 5% TCA (aqueous), which was vortexed and centrifuged glomerular damage [12] .
at 4000 g for 10 min; 500 ml 0.6% TBA (aqueous) was added to the deproteinized supernatant (700 ml ), vortexed and then reacted for 45 min at 90°C. After cooling at 4°C and a final centrifuge at 4000 g for 10 min, an aliquot (120 ml ) was
Subjects and methods
directly injected onto the HPLC.
Chemicals and reagents HPLC separation
Chemicals and reagents were of the highest analytical grade available and were as follows: 1,1,3,3-tetraethoxypropane The separation of the MDA-( TBA) 2 adduct was performed using the automated WatersTM HPLC system (510 Pump, (TEP), trichloroacetic acid (TCA), phosphoric acid, 2-thiobarbituric acid ( TBA), butylated hydroxytoluene 717 Autosampler and 486 Detector (at 532 nm), driven by
The analytical column was a reverse phase silica based C 18 column, (Spherisorb 5ODS 2, HPLC Technology Ltd ( Warrington, Cheshire, England )), with column dimensions of 25 cm×4.6 mm and a C 8 guard column (HPLC Technology Ltd ). The elution buffer was determined to be 65% 50 mM KH 2 PO 4 -KOH, pH 7.0, 35% MeOH, which was degassed under vacuum through a 0.45 mM filter (Millipore, type HAWP). The sample run was 10 min, with a flow rate of 1.2 ml/min, an injection volume of 120 ml, and visible detection at 532 nm.
All standards and samples were run and data analysed automatically via the Millenium software package. Mean peak area was determined for each sample ran in duplicate and the levels of MDA were calculated directly from the calibration of the TEP standards. Statistical analysis was performed using the non-99496x-708, r2=0.998. parametric Mann-Whitney U test. A P value of <0.05 was considered to indicate a significant difference.
Results

Method optimization
The existing method [11,13] was limited by the necessary but time consuming column washing procedures after each run and the short column life, i.e. only 60 and 300 runs quoted for the guard column and analytical column respectively. This may be attributed to protein contamination of the columns, which is irreversible and will lead to loss of sensitivity, resolution, and drifting retention times. We have investigated the effect of acid extraction (a simple method for protein removal ) on the TBA reaction and HPLC separation. calibration sensitivity using phosphoric, perchloric and TCA at 5% strength. TCA was therefore chosen estimated by analysis of 15 replicates of the blank because of its more common usage in protein removal, solvent in triplicate. The detection limit was determined as a result of its lower toxicity. MDA recovery of TEP as 0.055 mM MDA in a plasma sample, which equates spiked control plasma samples were similar using hot to 6.60 pmol MDA for a 120 ml injection. (90°C ) and cold (room temperature) extraction, unlike a previous study where MDA levels were higher in tissue samples using hot TCA incubation [14] .
Precision, interferences, sample stability, and column life Calibration and detection limit
Aliquots taken from pooled plasma of healthy controls were spiked with 75, 150 or 225 mM TEP The assay was calibrated from 0.25 to 1.0 mM TEP. A typical calibration plot is shown in Figure 1 , with a standards to give a low, medium, and high range of MDA concentrations. Within-run precision was regression line corresponding to y=99496×-708, r2= 0.998. The calibration was linear to at least 10.0 mM assessed by analysing 10 replicates of the three pools.
Between-run precision was determined by carrying TEP.
A typical chromatogram of a plasma sample is out duplicate measurements of the three pools on 10 different occasions. The within-run and between-run shown in Figure 2 . The average retention time of the MDA-( TBA) 2 adduct was 7.0 min at a flow rate of precision was less than 4.5% and 10.0% respectively ( Table 1 ). 1.2 ml/min. The initial peak (at about 3 min), may be attributed to non-retained plasma components, which
We investigated potential interference from a range of substances, including haemoglobin, triglyceride, were unreactive to TBA. The second peak (4.2 min) was TBA complexed with a variety of components, bilirubin, urea, and creatinine. The mean analytical recovery was 101% (range: 97-120%), despite increasincluding aldehydes other than MDA.
The detection limit was defined as two times the ing additions of interferent up to final concentrations of haemoglobin (6 g/l ), triglyceride (16 mM ), bilirubin standard deviation of the blank response, and was Fig. 3 . MDA levels in various subject groups. 1, Healthy controls (n=40); 2, transplants (n=40); 3, diabetic ESRF (n=20); 4, non-(400 mM ), creatinine (1000 mM ), and urea (50 mM ). diabetic ESRF (n=20); 5, CRF (n=40). Results are expressed as mean±SD. *P<0.001, **P=0.008 vs healthy controls.
Similar recovery was obtained from MDA spiked to a uraemic and healthy control plasma pool, suggesting little interferences from the uraemic milieu. patients (0.32±0.14 mM and 0.32±0.09 mM ), when BHT, an antioxidant, is added to the plasma sample compared to healthy controls (0.11±0.03 mM ). There before the TBA incubation to minimize lipid peroxida-were no significant differences between patients with tion during the heating stage. Therefore MDA levels ESRF due to diabetic nephropathy compared to those should reflect in vivo oxidation and not enhanced with other causes of ESRF. Levels in healthy controls production during the sample pre-treatment. It is and transplanted patients (0.12±0.03 mM MDA) possible that the stability of the sample may be were similar. improved by adding BHT to the fresh plasma before
There was a poor degree of correlation between storage at −70°C. This was investigated by adding MDA and creatinine levels in the CRF group and BHT to low, medium, and high plasma TEP spikes in transplant group (r2=0.05, n=80), as shown in fresh control plasma pools and analysing for MDA Figure 4 . MDA levels were significantly higher in levels after storage for 1, 8, 15 and 60 days. The the glomerular disease group (0.16±0.06 mM ) storage of samples for up to 14 days had no significant compared with the non-glomerular disease group effect on MDA levels, but the average intra-assay (0.12±0.04 mM ), P=0.002. precision of the untreated plasma samples was lower (6.8%) than the BHT treated samples (10.7%). There was a slight reduction in oxidation, which occurred on Discussion storage for 60 days at −70°C, with an average increase of 9% and 17% to MDA levels for the BHT and The determination of MDA is one of the most untreated samples respectively. It was not possible to commonly used methods for monitoring lipid peroxbatch samples with BHT, because of the loss in idation in biological samples. The frequently used precision.
TBARS method is fairly sensitive but not specific. Column life was significantly improved compared to the existing method, in which protein contamination of the analytical HPLC column resulted in irreversible peak broadening and drifting retention times after approximately 200 injections. This compares with an average of 800 runs over each of three columns with our modified method.
Sample analysis
The serum creatinine concentrations were less than 120 mmol/l in the healthy controls and greater than 500 mmol/l in the ESRF group. The creatinine concentrations (mean±SEM (mmol/l )) were also 182±16 (transplant), 300±35 (CRF ), 294±46 (CRF, group 1) and 307±54 (CRF, group 2). Figure 3 shows that MDA levels (mean±SD) were significantly higher in plasma from the group of CRF Fig. 4 . A correlation of MDA vs creatinine in the CRF and transplant groups (r2=0.05, n=80). patients (0.14±0.06 mM ) and the two groups of ESRF Recently, various HPLC methods have been applied which had renal impairment due to ongoing glomerulonephritis and the other whose renal failure was to improve the specificity of the TBA reaction. We have adapted an existing HPLC method [11, 13] , by due to non-glomerular and non-inflammatory causes.
Both groups were matched for serum creatinine. introducing an acid deproteinisation step, using TCA prior to TBA incubation. This has resulted in more There was a significant increase in MDA levels in the glomerulonephritis group, which suggests that there is than a three-fold improvement in column life, with similar sensitivity and without the need for extensive oxidative injury independent of the degree of renal impairment and this is supported by the demonstrapre-treatment.
Using this method, we have found that patients on tion, using other methodologies, of the involvement of reactive oxygen species in experimental nephritis HD and CRF patients had significantly higher MDA levels than healthy controls. Well-functioning renal [2] .
In conclusion, we have developed and validated transplant patients were no different from controls. Previous research has concentrated upon the HD an analytical HPLC method for determination of malondialdehyde in plasma, which is simple to group, where enhanced lipid peroxidation may result from free radical activity generated by complement perform, has high sensitivity and specificity and results in substantial improvement in HPLC column life. This activation and release of cytokines during the dialysis procedure, caused by exposure of blood to bio-incom-simple and reproducible technique offers an opportunity to further characterize the role of oxidative injury patible dialysis membranes. We have found high MDA levels in the ESRF group, which maybe attributed to in the pathogenesis of both experimental and clinical glomerular inflammation. their exposure to the Haemophan membrane.
There is a wide variation in the published levels of MDA in the plasma of HD patients as measured by Acknowledgements. J. Templar was supported by a research grant from the Special Trustees, Royal London Hospital.
the TBARS method, with the majority showing an increase compared to controls [15] , whilst others showed no difference [16 ] . These findings reflect the
